Presurgical Evaluation of Medically Intractable Epilepsy: Multimedia

References

1. Acharya JN, Dinner DS. Use of the intracarotid amobarbital procedure in the evaluation of memory. J Clin Neurophysiol. Jul 1997;14(4):311-25. [Medline].

2. Bastos AC, Comeau RM, Andermann F. Diagnosis of subtle focal dysplastic lesions: curvilinear reformatting from three-dimensional magnetic resonance imaging. Ann Neurol. Jul 1999;46(1):88-94. [Medline].

3. Baumgartner C, Pataraia E, Lindinger G. Magnetoencephalography in focal epilepsy. Epilepsia. 2000;41 Suppl 3:S39-47. [Medline].

4. Bautista RE, Spencer DD, Spencer SS. EEG findings in frontal lobe epilepsies. Neurology. Jun 1998;50(6):1765-71. [Medline].

5. Blume WT, Pillay N. Electrographic and clinical correlates of secondary bilateral synchrony. Epilepsia. Nov-Dec 1985;26(6):636-41. [Medline].

6. Buchtel HA, Passaro EA, Selwa LM. Sodium methohexital (brevital) as an anesthetic in the Wada test. Epilepsia. Sep 2002;43(9):1056-61. [Medline].

7. Burdette DE, Sakurai SY, Henry TR. Temporal lobe central benzodiazepine binding in unilateral mesial temporal lobe epilepsy. Neurology. May 1995;45(5):934-41. [Medline].

8. Burnstine TH, Vining EP, Uematsu S. Multifocal independent epileptiform discharges in children: ictal correlates and surgical therapy. Neurology. Aug 1991;41(8):1223-8. [Medline].

9. Chan S, Chin SS, Nordli DR. Prospective magnetic resonance imaging identification of focal cortical dysplasia, including the non-balloon cell subtype. Prospective magnetic resonance imaging identification of focal cortical dysplasi. Nov 1998;44(5):749-57. [Medline].

10. Chugani DC, Muzik O, Chakraborty P. Human brain serotonin synthesis capacity measured in vivo with alpha-[C-11]methyl-L-tryptophan. Synapse. Jan 1998;28(1):33-43. [Medline].

11. Chugani HT, Chugani DC. Imaging of serotonin mechanisms in epilepsy. Epilepsy Curr. Nov-Dec 2005;5(6):201-6. [Medline].

12. Colliot O, Bernasconi N, Khalili N. Individual voxel-based analysis of gray matter in focal cortical dysplasia. Neuroimage. Jan 1 2006;29(1):162-71. [Medline].

13. Colliot O, Antel SB, Naessens VB. In vivo profiling of focal cortical dysplasia on high-resolution MRI with computational models. Epilepsia. Jan 2006;47(1):134-42. [Medline].

14. Detre JA, Sirven JI, Alsop DC. Localization of subclinical ictal activity by functional magnetic resonance imaging: correlation with invasive monitoring. Ann Neurol. Oct 1995;38(4):618-24. [Medline].

15. Dobesberger J, Walser G, Embacher N. Gyratory seizures revisited: a video-EEG study. Neurology. Jun 14 2005;64(11):1884-7. [Medline].

16. Drzezga A, Arnold S, Minoshima S. 18F-FDG PET studies in patients with extratemporal and temporal epilepsy: evaluation of an observer-independent analysis. J Nucl Med. May 1999;40(5):737-46. [Medline].

17. Duncan JS. Magnetic resonance spectroscopy. Epilepsia. Jul 1996;37(7):598-605. [Medline].

18. Duncan JS. Imaging and epilepsy. Brain. Feb 1997;120 ( Pt 2):339-77. [Medline].

19. Ebersole JS. Magnetoencephalography/magnetic source imaging in the assessment of patients with epilepsy. Epilepsia. 1997;38 Suppl 4:S1-5. [Medline].

20. Ebersole JS, Pacia SV. Localization of temporal lobe foci by ictal EEG patterns. Epilepsia. Apr 1996;37(4):386-99. [Medline].

21. Eliashiv DS, Elsas SM, Squires K. Ictal magnetic source imaging as a localizing tool in partial epilepsy. Neurology. Nov 26 2002;59(10):1600-10. [Medline].

22. Engel J Jr, Henry TR, Swartz BE. Positron emission tomography in frontal lobe epilepsy. Adv Neurol. 1995;66:223-38; discussion 238-41. [Medline].

23. Engel J Jr. Surgery for seizures. N Engl J Med. Mar 7 1996;334(10):647-52. [Medline].

24. Engel J Jr. Update on surgical treatment of the epilepsies. Summary of the Second International Palm Desert Conference on the Surgical Treatment of the Epilepsies (1992). Neurology. Aug 1993;43(8):1612-7. [Medline].

25. Fakhoury T, Abou-Khalil B. Association of ipsilateral head turning and dystonia in temporal lobe seizures. Epilepsia. Nov 1995;36(11):1065-70. [Medline].

26. Fedi M, Reutens DC, Andermann F. alpha-[11C]-Methyl-L-tryptophan PET identifies the epileptogenic tuber and correlates with interictal spike frequency. Epilepsy Res. Jan 2003;52(3):203-13. [Medline].

27. Fedi M, Reutens D, Okazawa H. Localizing value of alpha-methyl-L-tryptophan PET in intractable epilepsy of neocortical origin. Neurology. Nov 13 2001;57(9):1629-36. [Medline].

28. Fischer MJ, Scheler G, Stefan H. Utilization of magnetoencephalography results to obtain favourable outcomes in epilepsy surgery. Brain. Jan 2005;128(Pt 1):153-7. [Medline].

29. Foldvary N, Lee N, Hanson MW. Correlation of hippocampal neuronal density and FDG-PET in mesial temporal lobe epilepsy. Epilepsia. Jan 1999;40(1):26-9. [Medline].

30. French JA, Williamson PD, Thadani VM. Characteristics of medial temporal lobe epilepsy: I. Results of history and physical examination. Ann Neurol. Dec 1993;34(6):774-80. [Medline].

31. Geyer JD, Payne TA, Faught E. Postictal nose-rubbing in the diagnosis, lateralization, and localization of seizures. Neurology. Mar 10 1999;52(4):743-5. [Medline].

32. Gloor P, Salanova V, Olivier A. The human dorsal hippocampal commissure. An anatomically identifiable and functional pathway. Brain. Oct 1993;116 ( Pt 5):1249-73. [Medline].

33. Grant PE, Barkovich AJ, Wald LL. High-resolution surface-coil MR of cortical lesions in medically refractory epilepsy: a prospective study. Am J Neuroradiol. Feb 1997;18(2):291-301. [Medline].

34. Hamer HM, Morris HH, Mascha EJ. Complications of invasive video-EEG monitoring with subdural grid electrodes. Neurology. Jan 8 2002;58(1):97-103. [Medline].

35. Harvey AS, Hopkins IJ, Bowe JM. Frontal lobe epilepsy: clinical seizure characteristics and localization with ictal 99mTc-HMPAO SPECT. Neurology. Oct 1993;43(10):1966-80. [Medline].

36. Henry TR. Functional neuroimaging with positron emission tomography. Epilepsia. Dec 1996;37(12):1141-54. [Medline].

37. Henry TR, Babb TL, Engel J Jr. Hippocampal neuronal loss and regional hypometabolism in temporal lobe epilepsy. Ann Neurol. Dec 1994;36(6):925-7. [Medline].

38. Henry TR, Drury I. Non-epileptic seizures in temporal lobectomy candidates with medically refractory seizures. Neurology. May 1997;48(5):1374-82. [Medline].

39. Henry TR, Frey KA, Sackellares JC. In vivo cerebral metabolism and central benzodiazepine-receptor binding in temporal lobe epilepsy. Neurology. Oct 1993;43(10):1998-2006. [Medline].

40. Hermann BP, Wyler AR, Richey ET. Wisconsin Card Sorting Test performance in patients with complex partial seizures of temporal-lobe origin. J Clin Exp Neuropsychol. Aug 1988;10(4):467-76. [Medline].

41. Ho SS, Berkovic SF, Newton MR. Parietal lobe epilepsy: clinical features and seizure localization by ictal SPECT. Neurology. Dec 1994;44(12):2277-84. [Medline].

42. Ho SS, Berkovic SF, Berlangieri SU. Comparison of ictal SPECT and interictal PET in the presurgical evaluation of temporal lobe epilepsy. Ann Neurol. Jun 1995;37(6):738-45. [Medline].

43. Ho SS, Kuzniecky RI, Gilliam F. Temporal lobe developmental malformations and epilepsy: dual pathology and bilateral hippocampal abnormalities. Neurology. Mar 1998;50(3):748-54. [Medline].

44. Jack CR Jr, Sharbrough FW, Cascino GD. Magnetic resonance image-based hippocampal volumetry: correlation with outcome after temporal lobectomy. Ann Neurol. Feb 1992;31(2):138-46. [Medline].

45. Jack CR Jr, Rydberg CH, Krecke KN. Mesial temporal sclerosis: diagnosis with fluid-attenuated inversion- recovery versus spin-echo MR imaging. Radiology. May 1996;199(2):367-73. [Medline].

46. Jackson GD, Kuzniecky RI, Cascino GD. Hippocampal sclerosis without detectable hippocampal atrophy. Neurology. Jan 1994;44(1):42-6. [Medline].

47. Jackson GD, Connelly A, Cross JH. Functional magnetic resonance imaging of focal seizures. Neurology. May 1994;44(5):850-6. [Medline].

48. Juhasz C, Chugani DC, Muzik O. Alpha-methyl-L-tryptophan PET detects epileptogenic cortex in children with intractable epilepsy. Neurology. Mar 25 2003;60(6):960-8. [Medline].

49. Juhasz C, Chugani DC, Padhye UN. Evaluation with alpha-[11C]methyl-L-tryptophan positron emission tomography for reoperation after failed epilepsy surgery. Epilepsia. Feb 2004;45(2):124-30. [Medline].

50. Kagawa K, Chugani DC, Asano E. Epilepsy surgery outcome in children with tuberous sclerosis complex evaluated with alpha-[11C]methyl-L-tryptophan positron emission tomography (PET). J Child Neurol. May 2005;20(5):429-38. [Medline].

51. Kernan JC, Devinsky O, Luciano DJ. Lateralizing significance of head and eye deviation in secondary generalized tonic-clonic seizures. Neurology. Jul 1993;43(7):1308-10. [Medline].

52. Kettenmann B, Feichtinger M, Tilz C, et al. Comparison of clonidine to sleep deprivation in their potential ability to induce spike and sharp wave activity. Epilepsia. 2002;43:314.

53. Knake S, Triantafyllou C, Wald LL. 3T phased array MRI improves the presurgical evaluation in focal epilepsies: a prospective study. Neurology. Oct 11 2005;65(7):1026-31. [Medline].

54. Kneebone AC, Chelune GJ, Dinner DS. Intracarotid amobarbital procedure as a predictor of material-specific memory change after anterior temporal lobectomy. Epilepsia. Sep 1995;36(9):857-65. [Medline].

55. Knowlton RC, Laxer KD, Aminoff MJ. Magnetoencephalography in partial epilepsy: clinical yield and localization accuracy. Ann Neurol. Oct 1997;42(4):622-31. [Medline].

56. Knowlton RC, Lawn ND, Mountz JM. Ictal SPECT analysis in epilepsy: subtraction and statistical parametric mapping techniques. Neurology. Jul 13 2004;63(1):10-5. [Medline].

57. Knowlton RC. The role of FDG-PET, ictal SPECT, and MEG in the epilepsy surgery evaluation. Epilepsy Behav. Feb 2006;8(1):91-101. [Medline].

58. Knowlton RC, Shih J. Magnetoencephalography in epilepsy. Epilepsia. 2004;45 Suppl 4:61-71. [Medline].

59. Koepp MJ, Richardson MP, Labbe C. 11C-flumazenil PET, volumetric MRI, and quantitative pathology in mesial temporal lobe epilepsy. Neurology. Sep 1997;49(3):764-73. [Medline].

60. Koepp MJ, Hand KS, Labbe C. In vivo [11C]flumazenil-PET correlates with ex vivo [3H]flumazenil autoradiography in hippocampal sclerosis. Ann Neurol. May 1998;43(5):618-26. [Medline].

61. Kotagal P, Arunkumar GS. Lateral frontal lobe seizures. Epilepsia. 1998;39 Suppl 4:S62-8. [Medline].

62. Kotagal P, Luders H, Morris HH. Dystonic posturing in complex partial seizures of temporal lobe onset: a new lateralizing sign. Neurology. Feb 1989;39(2 Pt 1):196-201. [Medline].

63. Kotagal P, Bleasel A, Geller E. Lateralizing value of asymmetric tonic limb posturing observed in secondarily generalized tonic-clonic seizures. Epilepsia. Apr 2000;41(4):457-62. [Medline].

64. Krakow K, Woermann FG, Symms MR. EEG-triggered functional MRI of interictal epileptiform activity in patients with partial seizures. Brain. Sep 1999;122 ( Pt 9):1679-88. [Medline].

65. Kuzniecky R, Hugg JW, Hetherington H. Relative utility of 1H spectroscopic imaging and hippocampal volumetry in the lateralization of mesial temporal lobe epilepsy. Neurology. Jul 1998;51(1):66-71. [Medline].

66. Kuzniecky R, Ho SS, Martin R. Temporal lobe developmental malformations and hippocampal sclerosis: epilepsy surgical outcome. Neurology. Feb 1999;52(3):479-84. [Medline].

67. Kuzniecky R, Hugg J, Hetherington H. Predictive value of 1H MRSI for outcome in temporal lobectomy. Neurology. Sep 11 1999;53(4):694-8. [Medline].

68. Kuzniecky RI, Bilir E, Gilliam F. Multimodality MRI in mesial temporal sclerosis: relative sensitivity and specificity. Neurology. Sep 1997;49(3):774-8. [Medline].

69. Lee SA, Spencer DD, Spencer SS. Intracranial EEG seizure-onset patterns in neocortical epilepsy. Epilepsia. Mar 2000;41(3):297-307. [Medline].

70. Leutmezer F, Woginger S, Antoni E. Asymmetric ending of secondarily generalized seizures: a lateralizing sign in TLE. Neurology. Oct 22 2002;59(8):1252-4. [Medline].

71. Levesque MF, Nakasato N, Vinters HV. Surgical treatment of limbic epilepsy associated with extrahippocampal lesions: the problem of dual pathology. J Neurosurg. Sep 1991;75(3):364-70. [Medline].

72. Li LM, Cendes F, Watson C. Surgical treatment of patients with single and dual pathology: relevance of lesion and of hippocampal atrophy to seizure outcome. Neurology. Feb 1997;48(2):437-44. [Medline].

73. Lieb JP, Engel J Jr, Babb TL. Interhemispheric propagation time of human hippocampal seizures. I. Relationship to surgical outcome. Epilepsia. May-Jun 1986;27(3):286-93. [Medline].

74. Lieb JP, Babb TL. Interhemispheric propagation time of human hippocampal seizures: II. Relationship to pathology and cell density. Epilepsia. May-Jun 1986;27(3):294-300. [Medline].

75. Lin JJ, Salamon N, Dutton RA. Three-dimensional preoperative maps of hippocampal atrophy predict surgical outcomes in temporal lobe epilepsy. Neurology. Oct 11 2005;65(7):1094-7. [Medline].

76. Loddenkemper T, Kotagal P. Lateralizing signs during seizures in focal epilepsy. Epilepsy Behav. Aug 2005;7(1):1-17. [Medline].

77. Loring DW, Meador KJ, Lee GP. Wada memory asymmetries predict verbal memory decline after anterior temporal lobectomy. Neurology. Jul 1995;45(7):1329-33. [Medline].

78. Loring DW, Meador KJ, Lee GP. Wada memory performance predicts seizure outcome following anterior temporal lobectomy. Neurology. Dec 1994;44(12):2322-4. [Medline].

79. Mamelak AN, Lopez N, Akhtari M. Magnetoencephalography-directed surgery in patients with neocortical epilepsy. J Neurosurg. Oct 2002;97(4):865-73. [Medline].

80. Manford M, Fish DR, Shorvon SD. An analysis of clinical seizure patterns and their localizing value in frontal and temporal lobe epilepsies. Brain. Feb 1996;119 ( Pt 1):17-40. [Medline].

81. Minassian BA, Otsubo H, Weiss S. Magnetoencephalographic localization in pediatric epilepsy surgery: comparison with invasive intracranial electroencephalography. Ann Neurol. Oct 1999;46(4):627-33. [Medline].

82. Moseley ME, Glover GH. Functional MR imaging. Capabilities and limitations. Neuroimaging Clin N Am. May 1995;5(2):161-91. [Medline].

83. Newton MR, Berkovic SF, Austin MC. Postictal switch in blood flow distribution and temporal lobe seizures. J Neurol Neurosurg Psychiatry. Oct 1992;55(10):891-4. [Medline].

84. O''Brien TJ, Newton MR, Cook MJ. Hippocampal atrophy is not a major determinant of regional hypometabolism in temporal lobe epilepsy. Epilepsia. Jan 1997;38(1):74-80. [Medline].

85. O''Brien TJ, So EL, Mullan BP. Subtraction ictal SPECT co-registered to MRI improves clinical usefulness of SPECT in localizing the surgical seizure focus. Neurology. Feb 1998;50(2):445-54. [Medline].

86. O''Brien TJ, So EL, Mullan BP. Subtraction SPECT co-registered to MRI improves postictal SPECT localization of seizure foci. Neurology. Jan 1 1999;52(1):137-46. [Medline].

87. Pacia SV, Ebersole JS. Intracranial EEG substrates of scalp ictal patterns from temporal lobe foci. Epilepsia. Jun 1997;38(6):642-54. [Medline].

88. Pacia SV, Ebersole JS. Intracranial EEG in temporal lobe epilepsy. J Clin Neurophysiol. Sep 1999;16(5):399-407. [Medline].

89. Passaro EA, Bookheimer S. Functional MRI in apatient with continuous occipital seizures with eyes closed. American Clinical Neurophysiology Society Abstract. 1995.

90. Passaro EA, Minoshima S, Nasreddine W. Three dimensional stereotactic surface projection studies in cryptogenic temporal lobe epilepsy. Epilepsia. 1999;40 (suppl 7):178.

91. Pataraia E, Lurger S, Serles W. Ictal scalp EEG in unilateral mesial temporal lobe epilepsy. Epilepsia. Jun 1998;39(6):608-14. [Medline].

92. Privitera M, Kohler C, Cahill W. Postictal language dysfunction in patients with right or bilateral hemispheric language localization. Epilepsia. Oct 1996;37(10):936-41. [Medline].

93. Privitera MD, Morris GL, Gilliam F. Postictal language assessment and lateralization of complex partial seizures. Ann Neurol. Sep 1991;30(3):391-6. [Medline].

94. Rausch R, Babb TL, Engel J Jr. Memory following intracarotid amobarbital injection contralateral to hippocampal damage. Arch Neurol. Jul 1989;46(7):783-8. [Medline].

95. Rheims S, Demarquay G, Isnard J. Ipsilateral head deviation in frontal lobe seizures. Epilepsia. Nov 2005;46(11):1750-3. [Medline].

96. Richardson MP, Koepp MJ, Brooks DJ. Benzodiazepine receptors in focal epilepsy with cortical dysgenesis: an 11C-flumazenil PET study. Ann Neurol. Aug 1996;40(2):188-98. [Medline].

97. Richardson MP, Koepp MJ, Brooks DJ. 11C-flumazenil PET in neocortical epilepsy. Neurology. Aug 1998;51(2):485-92. [Medline].

98. Risinger MW, Engel J Jr, Van Ness PC. Ictal localization of temporal lobe seizures with scalp/sphenoidal recordings. Neurology. Oct 1989;39(10):1288-93. [Medline].

99. Rosenow F, Luders H. Presurgical evaluation of epilepsy. Brain. Sep 2001;124(Pt 9):1683-700. [Medline].

100. Savic I, Persson A, Roland P. In-vivo demonstration of reduced benzodiazepine receptor binding in human epileptic foci. Lancet. Oct 15 1988;2(8616):863-6. [Medline].

101. Savic I, Thorell JO, Roland P. [11C]flumazenil positron emission tomography visualizes frontal epileptogenic regions. Epilepsia. Dec 1995;36(12):1225-32. [Medline].

102. Savic I, Lindstrom P, Gulyas B. Limbic reductions of 5-HT1A receptor binding in human temporal lobe epilepsy. Neurology. Apr 27 2004;62(8):1343-51. [Medline].

103. Schulz R, Luders HO, Tuxhorn I. Localization of epileptic auras induced on stimulation by subdural electrodes. Epilepsia. Dec 1997;38(12):1321-9. [Medline].

104. Serles W, Pataraia E, Bacher J. Clinical seizure lateralization in mesial temporal lobe epilepsy: differences between patients with unitemporal and bitemporal interictal spikes. Neurology. Mar 1998;50(3):742-7. [Medline].

105. Serles W, Caramanos Z, Lindinger G. Combining ictal surface-electroencephalography and seizure semiology improves patient lateralization in temporal lobe epilepsy. Epilepsia. Dec 2000;41(12):1567-73. [Medline].

106. Shields WD, Duchowny MS, Holmes GL. Surgically remediable syndromes of infancy and early childhood. In: Surgical Treatment of the Epilepsies. 2nd ed. New York: Raven Press;1993:35-48.

107. Siegel AM, Williamson PD, Roberts DW. Localized pain associated with seizures originating in the parietal lobe. Epilepsia. Jul 1999;40(7):845-55. [Medline].

108. Sisodiya SM, Stevens JM, Fish DR. The demonstration of gyral abnormalities in patients with cryptogenic partial epilepsy using three-dimensional MRI. Arch Neurol. Jan 1996;53(1):28-34. [Medline].

109. So N, Olivier A, Andermann F. Results of surgical treatment in patients with bitemporal epileptiform abnormalities. Ann Neurol. May 1989;25(5):432-9. [Medline].

110. Spencer SS. The relative contributions of MRI, SPECT, and PET imaging in epilepsy. Epilepsia. 1994;35 Suppl 6:S72-89. [Medline].

111. Sperling MR, Saykin AJ, Glosser G. Predictors of outcome after anterior temporal lobectomy: the intracarotid amobarbital test. Neurology. Dec 1994;44(12):2325-30. [Medline].

112. Stefan H, Hummel C, Scheler G. Magnetic brain source imaging of focal epileptic activity: a synopsis of 455 cases. Brain. Nov 2003;126(Pt 11):2396-405. [Medline].

113. Sutula T, Cascino G, Cavazos J. Mossy fiber synaptic reorganization in the epileptic human temporal lobe. Ann Neurol. Sep 1989;26(3):321-30. [Medline].

114. Swartz BW, Khonsari A, Vrown C. Improved sensitivity of 18FDG-positron emission tomography scans in frontal and "frontal plus" epilepsy. Epilepsia. Apr 1995;36(4):388-95. [Medline].

115. Theodore WH, Sato S, Kufta CV. FDG-positron emission tomography and invasive EEG: seizure focus detection and surgical outcome. Epilepsia. Jan 1997;38(1):81-6. [Medline].

116. Tilz C, Hummel C, Kettenmann B. Ictal onset localization of epileptic seizures by magnetoencephalography. Acta Neurol Scand. Oct 2002;106(4):190-5. [Medline].

117. Toczek MT, Carson RE, Lang L. PET imaging of 5-HT1A receptor binding in patients with temporal lobe epilepsy. Neurology. Mar 11 2003;60(5):749-56. [Medline].

118. Trinka E, Walser G, Unterberger I. Asymmetric termination of secondarily generalized tonic-clonic seizures in temporal lobe epilepsy. Neurology. Oct 22 2002;59(8):1254-6. [Medline].

119. Vattipally VR, Bronen RA. MR imaging of epilepsy: strategies for successful interpretation. Neuroimaging Clin N Am. Aug 2004;14(3):349-72. [Medline].

120. Vinters HV, Armstrong DL, Babb TL. The neuropathology of human symptomatic epilepsy In: Surgical Treatment of the Epilepsies. 2nd ed. New York: Raven Press;1993.

121. Vossler DG, Kraemer DL, Knowlton RC. Temporal ictal electroencephalographic frequency correlates with hippocampal atrophy and sclerosis. Ann Neurol. Jun 1998;43(6):756-62. [Medline].

122. Williamson PD, French JA, Thadani VM. Characteristics of medial temporal lobe epilepsy: II. Interictal and ictal scalp electroencephalography, neuropsychological testing, neuroimaging, surgical results, and pathology. Ann Neurol. Dec 1993;34(6):781-7. [Medline].

123. Williamson PD, Boon PA, Thadani VM. Parietal lobe epilepsy: diagnostic considerations and results of surgery. Ann Neurol. Feb 1992;31(2):193-201. [Medline].

124. Williamson PD, Thadani VM, Darcey TM. Occipital lobe epilepsy: clinical characteristics, seizure spread patterns, and results of surgery. Ann Neurol. Jan 1992;31(1):3-13. [Medline].

125. Williamson PD, Thadani VM, French JA. Medial temporal lobe epilepsy: videotape analysis of objective clinical seizure characteristics. Epilepsia. Nov 1998;39(11):1182-8. [Medline].

126. Zubal IG, Spencer SS, Imam K. Difference images calculated from ictal and interictal technetium-99m- HMPAO SPECT scans of epilepsy. J Nucl Med. Apr 1995;36(4):684-9. [Medline].

Further Reading

Keywords

medically refractory epilepsy, refractory epilepsy, epilepsy surgery, seizure localization, intractable, presurgical evaluation of medically intractable epilepsy, seizure evaluation, long-term epilepsy monitoring, AEDs, antiepileptic medications, EEG monitoring for seizures

Contributor Information and Disclosures

Author

Erasmo A Passaro, MD, Director, Comprehensive Epilepsy Program/Clinical Neurophysiology Lab, Bayfront Medical Center
Erasmo A Passaro, MD is a member of the following medical societies: American Academy of Neurology, American Academy of Sleep Medicine, American Clinical Neurophysiology Society, American Epilepsy Society, and American Medical Association
Disclosure: Nothing to disclose.

Medical Editor

Claude G Wasterlain, MD, Vice-Chairperson, Professor, Department of Neurology, University of California at Los Angeles
Claude G Wasterlain, MD is a member of the following medical societies: American Academy of Neurology, American Epilepsy Society, American Federation for Medical Research, American Neurological Association, Royal Society of Medicine, and Society for Neuroscience
Disclosure: Nothing to disclose.

Pharmacy Editor

Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine
Disclosure: Nothing to disclose.

Managing Editor

Jose E Cavazos, MD, PhD, Assistant Professor, Departments of Medicine (Neurology), Pharmacology, and Physiology, University of Texas Health Science Center at San Antonio
Jose E Cavazos, MD, PhD is a member of the following medical societies: American Academy of Neurology, American Clinical Neurophysiology Society, American Epilepsy Society, and Society for Neuroscience
Disclosure: Glaxo-SmithKline Honoraria Speaking and teaching; Ortho-McNeil Neurologics Honoraria Speaking and teaching; UCB Pharma Honoraria Speaking and teaching

CME Editor

Selim R Benbadis, MD, Professor, Director of Comprehensive Epilepsy Program, Departments of Neurology and Neurosurgery, University of South Florida School of Medicine, Tampa General Hospital
Selim R Benbadis, MD is a member of the following medical societies: American Academy of Neurology, American Academy of Sleep Medicine, American Clinical Neurophysiology Society, American Epilepsy Society, and American Medical Association
Disclosure: Nothing to disclose.

Chief Editor

Nicholas Y Lorenzo, MD, Chief Editor, eMedicine Neurology; Consulting Staff, Neurology Specialists and Consultants
Nicholas Y Lorenzo, MD is a member of the following medical societies: Alpha Omega Alpha and American Academy of Neurology
Disclosure: Nothing to disclose.